Sectoral Asset Management »

Evommune shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 589k 17.12

More positions owned by Sectoral Asset Management

Evommune Com Shs (EVMN)
Contineum Therapeutics Cl A (CTNM)
Eli Lilly & Co. (LLY)
Shoulder Innovations Common Stock (SI)
UnitedHealth (UNH)
Amgen (AMGN)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Regeneron Pharmaceuticals (REGN)
Intuitive Surgic Com New (ISRG)
Boston Scientific Corporation (BSX)
Argenx Se Spn Sp Adr (ARGX)
Danaher Corporation (DHR)

View all positions for Sectoral Asset Management

Top funds holding Evommune

Marshall Wace
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Vanguard Group
American Century Companies
Geode Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Capricorn Fund Managers
TD Asset Management
State Street Corporation
Manufacturers Life Insurance Company
UBS Group
China Universal Asset Management

View all funds holding Evommune